Number of respondents by (selected*) first cancer site and date of diagnosis: Medicare Advantage

This table provides information about number of CAHPS survey respondents in SEER-CAHPS by selected first cancer sire and time between diagnosis and survey.

First cancer Total number of SEER linked patients First survey before month of first cancer diagnosis First survey within 2 years of first cancer diagnosis First survey within 3–5 years of first cancer diagnosis First survey within 6–10 years of first cancer diagnosis First survey within 11+ years of first cancer diagnosis
N % N % N % N % N %
Breast 67,496 27,340 40.51 8,243 12.21 7,991 11.84 10,929 16.19 12,993 19.25
Prostate 67,118 25,011 37.26 9,717 14.48 9,481 14.13 12,731 18.97 10,178 15.16
Lung and Bronchus 41,437 33,475 80.79 3,872 9.34 1,791 4.32 1,400 3.38 899 2.17
Colorectal 38,694 20,874 53.95 4,546 11.75 3,757 9.71 4,741 12.25 4,776 12.34
Melanoma Skin 21,972 10,936 49.77 2,577 11.73 2,460 11.20 2,893 13.17 3,106 14.14
Bladder 20,535 12,093 58.89 2,450 11.93 1,975 9.62 2,159 10.51 1,858 9.05
Non-Hodgkins Lymphoma 14,679 8,812 60.03 1,638 11.16 1,383 9.42 1,520 10.35 1,326 9.03
Uterine Corpus 11,695 4,635 39.63 1,302 11.13 1,336 11.42 1,827 15.62 2,595 22.19
Kidney/Renal Pelvis 11,190 6,238 55.75 1,389 12.41 1,203 10.75 1,319 11.79 1,041 9.30
Head/Neck 9,918 5,236 52.79 1,259 12.69 1,001 10.09 1,246 12.56 1,176 11.86
Leukemia 9,078 5,949 65.53 1,161 12.79 686 7.56 774 8.53 508 5.60
Pancreas 8,674 7,874 90.78 485 5.59 141 1.63 117 1.35 57 0.66
Stomach 5,108 3,677 71.99 565 11.06 300 5.87 316 6.19 250 4.89
Liver/Bile Duct 4,627 3,792 81.95 440 9.51 182 3.93 141 3.05 72 1.56
Ovary 3,995 2,428 60.78 453 11.34 286 7.16 322 8.06 506 12.67
Esophagus 2,793 2,199 78.73 259 9.27 133 4.76 135 4.83 67 2.40
Uterine Cervix 1,542 570 36.96 125 8.11 138 8.95 217 14.07 492 31.91

* Sites reflect most prevalent cancer sites in SEER-CAHPS.

Last Updated: 04 Jun, 2025